Suzuki, K.; Iwai, H.; Utsunomiya, K.; Kono, Y.; Watabe, T.; Kobayashi, Y.; Bui, D.V.; Sawada, S.; Yun, Y.; Mitani, A.;
et al. Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model. Int. J. Mol. Sci. 2022, 23, 9872.
https://doi.org/10.3390/ijms23179872
AMA Style
Suzuki K, Iwai H, Utsunomiya K, Kono Y, Watabe T, Kobayashi Y, Bui DV, Sawada S, Yun Y, Mitani A,
et al. Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model. International Journal of Molecular Sciences. 2022; 23(17):9872.
https://doi.org/10.3390/ijms23179872
Chicago/Turabian Style
Suzuki, Kensuke, Hiroshi Iwai, Keita Utsunomiya, Yumiko Kono, Tadashi Watabe, Yoshiki Kobayashi, Dan Van Bui, Shunsuke Sawada, Yasutaka Yun, Akitoshi Mitani,
and et al. 2022. "Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model" International Journal of Molecular Sciences 23, no. 17: 9872.
https://doi.org/10.3390/ijms23179872
APA Style
Suzuki, K., Iwai, H., Utsunomiya, K., Kono, Y., Watabe, T., Kobayashi, Y., Bui, D. V., Sawada, S., Yun, Y., Mitani, A., Fukui, K., Sakai, H., Chu, H. H., Linh, N. M., Tanigawa, N., & Kanda, A.
(2022). Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model. International Journal of Molecular Sciences, 23(17), 9872.
https://doi.org/10.3390/ijms23179872